AACR Calls on Congress to Summarily Reject the President’s FY2026 Budget Proposal for NIH
AACR shared a post on X:
“Today, the American Association for Cancer Research (AACR) called on Congress to reject the Administration’s nearly 40% cut to the NIH budget and allocate a bipartisan funding increase to $51.3 billion for the agency to accelerate progress for patients.
The Administration’s budget proposal would have serious negative consequences and destabilize our nation’s medical research enterprise, including halting critical clinical trials, disrupting the careers of cancer researchers, and jeopardizing patient access to new treatments.
These proposed cuts would hurt the U.S. economy and American competitiveness. Federal investments in biomedical research deliver significant economic returns—in fiscal year 2024, there was a $2.56 ROI in economic activity for every $1 invested in NIH research.”
Margaret Foti, CEO at American Association for Cancer Research, shared this post, adding:
“We are making tremendous strides in preventing and treating cancer due to decades of dedicated efforts by lawmakers, policymakers, cancer researchers, physician-scientists, and patient advocates.
Continued investment is needed to sustain these critical advances.”
More posts featuring FY2026 Budget Proposal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023